RxDoctor Payments DataLook up a doctor →

Robert Jamieson, MD

Psychiatry · Nashville, TNNPI 1184602757

Payments from drug & device makers

$141,447in general payments, 2019–2025

Across 1,114 payments — averaging $126.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$53K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$30K
  • Neurocrine Biosciences, Inc.$28K
  • Takeda Pharmaceuticals U.S.A., Inc.$12K
  • Sunovion Pharmaceuticals Inc.$9K
  • Teva Pharmaceuticals USA, Inc.$3K
  • plus $7K from 50 others

What the payments were for

  • Consulting fees$5,0214%
  • Speaking & faculty fees$119,73385%
  • Travel & lodging$1,4671%
  • Food & beverage$14,96911%
  • Education$2570%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)201$52,523
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)82$30,100
Neurocrine Biosciences, Inc.225$28,447
Takeda Pharmaceuticals U.S.A., Inc.44$11,539
Sunovion Pharmaceuticals Inc.29$9,190
Teva Pharmaceuticals USA, Inc.130$3,054
Otsuka America Pharmaceutical, Inc.55$818
Johnson & Johnson36$642
Alkermes, Inc.42$569
Lundbeck LLC23$482
Merck22$304
Vanda Pharmaceuticals Inc.19$297
Axsome Therapeutics, Inc.15$284
Amgen19$278
Novo Nordisk14$263
Bausch Health US, LLC14$253
Avanir Pharmaceuticals, Inc.9$199
Jazz Pharmaceuticals Inc.9$179
E.r. Squibb & Sons, L.L.C.16$174
Eisai Inc.19$171
Tris Pharma Inc9$171
Corium, LLC12$145
Adlon Therapeutics L.p.7$129
Sage Therapeutics, LLC3$107
Restor3d, Inc.1$98
Kowa Pharmaceuticals America, Inc.4$65
Livanova USA, Inc.3$63
Biohaven Pharmaceutical Holding Company Ltd.3$62
Supernus Pharmaceuticals, Inc.3$62
Lilly USA, LLC4$61
Novartis3$61
Almatica Pharma LLC3$55
Daiichi Sankyo Inc.3$46
Arbor Pharmaceuticals, Inc.2$41
Idorsia Pharmaceuticals US Inc2$40
Acadia Pharmaceuticals Inc2$39
Esperion Therapeutics, Inc.2$38
Pfizer3$37
Exact Sciences2$37
Vertical Pharmaceuticals, LLC2$33
Ironshore Pharmaceuticals Inc.2$33
CMP Pharma, Inc.2$30
GSK1$24
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$23
Harmony Biosciences LLC1$20
Phathom Pharmaceuticals, Inc.1$20
Endo Pharmaceuticals Inc.1$19
Hologic Sales And Service, LLC1$18
Dynavax Technologies Corporation1$17
Noven Therapeutics, LLC1$14
Neuronetics, Inc.1$14
Alfasigma USA, Inc.1$13
Amneal Pharmaceuticals LLC1$13
Ortho Dermatologics, A Division Of Bausch Health US, LLC1$13
Vistapharm, Inc.1$12
Validus Pharmaceuticals LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$141,447 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$29,237
Medicare patients
175
Services billed
238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate87$694,134
AustedoDeutetrabenazine18$351,574
LybalviOlanzapine/Samidorphan Malate27$75,321
NuedextaDextromethorphan Hbr/Quinidine32$49,795
RexultiBrexpiprazole25$42,567
VraylarCariprazine Hcl31$41,580
CaplytaLumateperone Tosylate20$38,205
Abilify MaintenaAripiprazole14$36,887
TrintellixVortioxetine Hydrobromide35$35,812
BelsomraSuvorexant62$26,606
Lurasidone Hcl37$19,322
Asenapine Maleate83$19,107
AuvelityDextromethorphan Hbr/Bupropion12$16,441
Clozapine OdtClozapine12$9,637
QuviviqDaridorexant Hcl18$9,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$28,447$694,13487 claims
Teva Pharmaceuticals USA, Inc.Austedo$3,054$351,57418 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$818$79,45439 claims
Alkermes, Inc.Lybalvi$569$75,32127 claims
Avanir Pharmaceuticals, Inc.Nuedexta$199$49,79532 claims
AbbVieVraylar$52,523$41,58031 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$30,100$38,20520 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$11,539$35,81235 claims
MerckBelsomra$304$26,60662 claims
Axsome Therapeutics, Inc.Auvelity$284$16,44112 claims
Idorsia Pharmaceuticals US IncQuviviq$40$9,24118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →